Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis

Overview of attention for article published in Journal of Neuroinflammation, June 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,023 followers.

Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis https://t.co/mleYHbsQIP https://t.co/2PiuIAwAiV

Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis https://t.co/pduFk4zwqO

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.